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PLoS Neglected Tropical Diseases is an
open-access community journal that serves
the needs of a small but active and robust
community of neglected tropical disease
(NTD) scientists, clinicians, and public
health and policy experts. As stewards of
that community, our editorial staff has
very much molded the journal according
to what we have learned from you in terms
of mission, priorities, and scope. In the
eighteen months since the launch of PLoS
Neglected Tropical Diseases, some of our most
interesting editorial discussions and que-
ries from authors are in regards to the
journal’s scope, particularly the specific
conditions defined as NTDs (http://www.
plosntds.org/static/scope.action).
What has emerged from these discus-
sions is a journal focused on a fairly
specific group of important infections
endemic in developing countries with
seven common features [1,2]: (1) the
NTDs occur in the setting of poverty
where they are the most prevalent infec-
tions afflicting ‘‘the bottom billion,’’ i.e.,
people living on less than US$1 per day
[3]; (2) they are chronic conditions—
people can harbor their NTDs for years
or decades; (3) they generally disable,
rather than kill; (4) they are frequently
disfiguring and stigmatizing [4]; (5) they
are not typically emerging in character;
instead, the NTDs have plagued human-
kind for centuries and many are described
in ancient texts [5]; (6) they are not just
diseases of poverty, but they also promote
poverty because of their effects on child
development, cognition, and education,
adult agricultural worker productivity, and
pregnancy outcome [3]; and (7) the NTDs
are a critical component of the ‘‘other
diseases’’ mentioned in the sixth Millenni-
um Development Goal (‘‘Combat HIV/
AIDS, malaria, and other diseases’’)
[1,2,6].
Helminths
There are certain diseases that easily
meet these criteria. A good example are
the helminth infections, especially the
most common ones, such as hookworm
infection, ascariasis, trichuriasis, strongy-
loidiasis, schistosomiasis, and lymphatic
filariasis—each affecting more than 100
million people in sub-Saharan Africa or
tropical regions of Asia and the Americas.
We have included many of the less
common helminthiases in our scope,
including food-borne trematode infections,
onchocerciasis, loiasis and other filarial
infections, cysticercosis and other cestodi-
ases, and other intestinal nematode infec-
tions. We also include helminth infections
that are not exclusively tropical, such as
enterobiasis, toxocariasis, and trichinello-
sis. In North America (and elsewhere in
temperate regions) helminth infections
such as ascariasis and strongyloidiasis are
still considered diseases that primarily
affect the poor, and they have been
designated by some as ‘‘neglected infec-
tions of poverty’’ [7,8]. In summary, we
would consider almost any human hel-
minth infections as an NTD and thus
within the scope of the journal.
Protozoa
Similarly, most of the protozoan infec-
tions, including Chagas disease, leishman-
iasis, human African trypanosomiasis, and
many of the intestinal protozoan infec-
tions, are also considered NTDs. Conspic-
uous by its absence on the protozoan
infection list is malaria. Certainly, no one
would question the devastating global
health impact of this disease, nor its
predilection to affect the poor. Moreover,
as with the NTDs, several investigators,
including Jeffrey Sachs and others, have
documented in some depth the poverty-
promoting impact of malaria [9,10]. We
have chosen to omit malaria from our list
of NTDs for three reasons. First, there is a
comparatively large community of investi-
gators working on malaria (in contrast to
the smaller NTD research community).
Second, while we acknowledge shortfalls
in funding [11], there have been impor-
tant infusions of funding and heightened
advocacy for malaria control in recent
times, including through the US Presi-
dent’s Malaria Initiative, The Global Fund
to Fight AIDS, Tuberculosis, and Malaria,
Roll Back Malaria, and several malaria
advocacy groups, including Malaria No
More (http://www.malarianomore.org/).
Third, malaria researchers already have a
very wide range of open-access venues for
their work, including the other six PLoS
journals, all of which have published
studies on malaria, as well as the Malaria
Journal, published by BioMed Central
(http://www.malariajournal.com/).
However, we continue to invite and
publish malaria papers that examine
malaria and NTD co-infection or co-
endemicity, such as a recent study we
published examining whether helminth
infection in children affects malaria sus-
ceptibility [12] and another that surveyed
trachoma and malaria together in Ethio-
pia [13]. In 2007, Ric Price and colleagues
made a cogent argument for considering
vivax malaria as a neglected disease and
we largely agree with their comments [14].
But after some lengthy editorial discus-
sions, we have decided for the moment to
hold off on opening the door completely to
papers on vivax malaria both because of
the availability of other open-access jour-
nals that have malaria in their scope, as
outlined above, and because of our
concerns that the number of submissions
Citation: Hotez PJ, Yamey G (2009) The Evolving Scope of PLoS Neglected Tropical Diseases. PLoS Negl Trop
Dis 3(2): e379. doi:10.1371/journal.pntd.0000379
Published February 24, 2009
Copyright:  2009 Hotez, Yamey. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
Funding: The authors received no specific funding to write this article.
Competing Interests: GY declares no competing interests. PJH is Co-Founder of the Global Network for
Neglected Tropical Diseases. He is an inventor on two international patents on hookworm vaccines.
* E-mail: mtmpjh@gwumc.edu or photez@gwu.edu (PJH); gyamey@plos.org (GY)
Peter J. Hotez is Editor-in-Chief of PLoS Neglected Tropical Diseases. He is Distinguished Research Professor, the
Walter G. Ross Professor, and Chair of the Department of Microbiology, Immunology, and Tropical Medicine at
The George Washington University, and President of the Sabin Vaccine Institute. Gavin Yamey is Senior Editor
of PLoS Medicine and Consulting Editor of PLoS Neglected Tropical Diseases.
www.plosntds.org 1 February 2009 | Volume 3 | Issue 2 | e379on this topic would overwhelm the papers
we are currently defining as NTDs.
Having said that, we want PLoS Neglected
Tropical Diseases to be a ‘‘living’’ journal
that reflects the needs of the community
and our scope will thus continue to evolve
over time. Therefore, on a case-by-case
basis we will consider papers on vivax
malaria and related topics.
Bacteria and Fungi
When it comes to the bacterial infec-
tions, chronic infections such as leprosy,
Buruli ulcer, and trachoma clearly qualify
as NTDs. Similarly, leptospirosis, relaps-
ing fever, and the treponematoses are
important neglected bacterial diseases.
We are not generally considering papers
on tuberculosis for publication for much
the same reason that we refrain from
considering malaria papers, i.e., there is a
sizeable group of comparatively well-
funded experts in the field of tuberculosis
and the disease falls in the scope of the
other six PLoS journals. However, we are
currently considering aspects of bovine
tuberculosis that pertain to health in
developing countries. Since the launch of
PLoS Neglected Tropical Diseases, we have
had several lively editorial discussions
about the important enteric bacterial
infections, such as cholera, salmonellosis,
and shigellosis. After talking to several
experts in the field, including Richard
Guerrant and Gerald Keusch, we are now
welcoming papers on these topics, partic-
ularly as they relate to disease in develop-
ing countries. We continue to consider
papers on tropical fungal infections, as well
as some selected non-infectious NTDs,
such as podoconiosis.
Viruses
We are not considering papers on HIV/
AIDS unless they pertain to NTD co-
infections—an example of a paper we
have published on HIV–NTD co-infection
was the systematic review by Judd Walson
and Grace John-Stewart that examined
whether treating helminth infection affects
the prognosis of patients with HIV-1 [15].
Among the other viral infections, we now
welcome papers on arboviral infections
and have taken measures to add experts in
this area on our editorial board. In
addition, we recognize the importance of
rabies as an NTD, as well as some of the
viral hemorrhagic fevers. Our journal
continues to publish papers on the insect
vectors that transmit NTD pathogens, as
well as papers on intermediate hosts such
as snails.
We consider PLoS Neglected Tropical
Diseases a work in progress that operates
in an iterative manner in order to best
serve the needs of the community. It is our
hope that the journal will continue to
attract new researchers to the field and, by
its heavy representation of editorial staff
from endemic countries, continue to build
scientific and public health capacity in
developing countries. We are working
particularly hard to reach out to authors
in low-income settings (see http://www.
plosntds.org/static/developing.action), for
example by providing additional editorial
support to authors whose first language is
not English. We are especially sensitive to
supporting women in the sciences, medi-
cine, and public health and this is also
reflected in the composition of our edito-
rial board. We further expect that papers
published in the Magazine section will
help to foster a cadre of NTD policy
experts. From the number and quality of
submissions received to date we feel that
we are meeting those needs. At the same
time, we very much want to hear from you
about how we might continue to fine tune
and improve the journal in order to ensure
that open access continually enhances this
important and vital pursuit. Please send us
your feedback by adding your annotations
to this article or starting a discussion
thread using our innovative online tools.
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